Zevra Therapeutics: A High-Stakes Bet in the Ultra-Rare Disease Arena
The Shifting Sands of Zevra: Cantor Fitzgerald Takes a Sobering Look
Zevra Therapeutics Shares Skyrocket Amid Intense Takeover Speculation